INTRODUCTION
============

The prevalence of obesity and type 2 diabetes mellitus (DM) is increasing worldwide among adolescents and young adults \[[@B1]\]. Impaired fasting glucose (IFG) and impaired glucose tolerance (collectively known as prediabetes) precede diabetes \[[@B2][@B3]\], and prediabetes is more prevalent in these age groups than is diabetes \[[@B4]\]. Children and adolescents with elevated fasting plasma glucose (FPG) have been predicted to have type 2 DM in young adulthood \[[@B5]\].

The diagnosis of diabetes and prediabetes has been traditionally based on the FPG and 2-hour plasma glucose levels in oral glucose tolerance tests (OGTTs). However, an International Expert Committee has recommended measurement of glycosylated hemoglobin (HbA1c) levels as the diagnostic method, with cutoff values of ≥6.5% for diabetes and ≥6.0% for high risk for diabetes \[[@B6]\]. The value for prediabetes recommended by the American Diabetes Association (ADA) is ≥5.7% \[[@B7]\]. The Korean Diabetes Association (KDA) has included HbA1c as a diagnostic test since 2011 \[[@B8]\].

HbA1c is a non-enzymatic glycosylated product of hemoglobin, and its level reflects the mean glucose concentration in the blood for the preceding 3 to 4 months. A high level of HbA1c is a risk factor for diabetes and diabetes-related complications according to epidemiologic studies \[[@B9][@B10][@B11]\]. Measurement of HbA1c levels has several advantages over measurement of FPG or 2-hour plasma glucose levels, which include no need for fasting, less inter-individual variability, and better biologic stability after sampling \[[@B6][@B12]\]. Although HbA1c has been used as a tool for detecting diabetes and prediabetes, diagnoses based on HbA1c levels are not always the same as those based on glucose levels \[[@B13][@B14][@B15]\]. Studies performed in obese Korean children and adolescents showed discordance between OGTT- and HbA1c-based results in predicting diabetes and prediabetes \[[@B16][@B17]\]. Several studies have revealed the differences in normative HbA1c values with respect to age, sex, and ethnicity \[[@B18][@B19]\]. Whether the HbA1c cutoff values for diabetes and prediabetes should be the same in adults versus adolescents is controversial \[[@B20][@B21][@B22]\]. Moreover, studies for the usefulness of HbA1c in detecting prediabetes and diabetes based on FPG in both general pediatric and young adult populations are lacking.

The aims of the present study were to assess the extent of agreement between diagnoses based on FPG versus HbA1c levels, to evaluate the diagnostic performance of HbA1c, and to determine the optimal HbA1c cutoff values for diabetes and prediabetes in youths and young adults by using nationally representative data of Korea.

METHODS
=======

Study participants
------------------

The data for the study were obtained from the Korea National Health and Nutrition Examination Survey (KNHANES) performed between 2011 and 2016. The KNHANES was a nationally representative cross-sectional examination of non-institutionalized Korean citizens with a multi-stage clustered probability design conducted by the Korea Centers for Disease Control and Prevention \[[@B23]\]. This survey aimed to assess the health and nutrition of Koreans, to monitor risk factors for major chronic diseases, and to provide reliable data for health policies \[[@B23]\]. The detailed methods for data collection by the KNHANES are described elsewhere \[[@B24]\].

A total of 47,464 individuals were enrolled in the KNHANES from 2011 to 2016. For this study, 9,502 subjects aged 10 to 29 years were considered as potential participants. Among them, 7,332 were included in the study after exclusion of participants who had fasted \<8 hours before sample collection (*n*=310), had no glucose or HbA1c data (*n*=1,647), were previously diagnosed with DM (*n*=11), were pregnant at the time of the survey (*n*=53), or had anemia with a hemoglobin level \<11.5 g/dL in children aged 10 to 11 years, \<12 g/dL in children aged 12 to 14 years and females aged ≥15 years, or \<13 g/dL for males aged ≥15 years (*n*=343) ([Fig. 1](#F1){ref-type="fig"}) \[[@B25]\]. Subjects with hemoglobinopathy were not considered for the present study, because the condition is extremely rare in the Korean population \[[@B26]\]. Among the 7,332 participants in the 2011 to 2016 KNHANES who met the inclusion criteria, 4,129 (45.1%) were in the youth group (10 to 19 years of age) and 3,203 (54.9%) were in the young adult group (20 to 29 years of age).

Subjects were divided into two groups according to age: the youth group (10 to 19 years of age) and the young adult group (20 to 29 years of age). In this study, DM by FPG (DM~FPG~) was defined as an FPG level ≥126 mg/dL, and IFG was defined as an FPG level between 100 and 125 mg/dL. We used the HbA1c cutoff criteria recommended by the ADA and KDA, namely, ≥6.5% for DM by HbA1c (DM~A1C~) and 5.7% to 6.4% for prediabetes by HbA1c (PreDM~A1C~) \[[@B7][@B8]\].

All subjects participated in the KNHANES voluntarily and provided informed consent. The protocol of the KNHANES was approved by the Institutional Review Board of the Korea Centers for Disease Control and Prevention (IRB No. 2011-02CON-06-C, 2012-01EXP-01-2C, 2013-07CON-03-4C, 2013-12EXP-03-5C) \[[@B23][@B24]\]. The present study was approved by the Institutional Review Board of Seoul National University Bundang Hospital (IRB No. X-1703-388-912). All procedures were performed in accordance with the Declaration of Helsinki.

Laboratory tests
----------------

Blood samples were drawn after overnight fasting by trained medical personnel. The samples were transported daily to the central laboratory and analyzed within 24 hours. FPG levels were measured by using the hexokinase method with a Hitachi Automatic Analyzer 7600 (Hitachi, Tokyo, Japan). HbA1c levels were measured via high performance liquid chromatography (HLC-723G7; Tosoh, Tokyo, Japan), which is the method certified by the National Glycohemoglobin Standardization Program \[[@B27]\]. The laboratory tests performed in the KNHANES underwent both internal and external quality controls three times a year. The detailed methods for anthropometric measurements and laboratory tests are described elsewhere \[[@B24]\].

Statistical analysis
--------------------

Statistical analyses were performed by using Stata version 14.2 software (StataCorp LP, College Station, TX, USA). Appropriate sample weights were used to adjust for the multi-stage clustered probability sample design. Taylor series linearization was used for variance estimation.

Results were expressed as weighted mean±standard error or number (weighted percent). Kappa coefficients were calculated to assess agreement between FPG and HbA1c results for the diagnosis of prediabetes and diabetes \[[@B28]\]. The diagnostic performance of HbA1c was evaluated in terms of sensitivity, specificity, positive predictive value (PPV), and negative predictive value at thresholds of 5.7% and 6.5%. Receiver operating characteristic (ROC) curves were generated to assess the ability of HbA1c to predict IFG and DM~FPG~ \[[@B29]\]. The equality of area under the curve (AUC) with a 95% confidence interval (CI) was evaluated. The optimal cutoff values were the points at which the ROC curve was closest to the point at which sensitivity and specificity were equal to 1. A *P* value \<0.05 was considered statistically significant.

RESULTS
=======

Characteristics of the study participants
-----------------------------------------

There was no sex difference found between the groups (males 54.6% for the youth group and 55.8% for the young adult group) ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). FPG and HbA1c levels were significantly higher in the youth group than in the young adults group (FPG 90.3±0.2 and 89.1±0.2 mg/dL; HbA1c 5.41%± 0.01% and 5.32%±0.01%, respectively). The values of all variables except for FPG and HbA1c levels were significantly higher in the young adult group than in the youth group ([Supplementary Table 1](#S1){ref-type="supplementary-material"}).

Distribution of prediabetes and diabetes by FPG and HbA1c values
----------------------------------------------------------------

In the youth group, HbA1c levels were as follows: 5.7% to 6.4% in 110 (32.5%) of the participants with IFG; and ≥6.5% in five (72.2%) of the participants with DM~FPG~ ([Table 1](#T1){ref-type="table"}). In the young adult group, the HbA1c levels were as follows: 5.7% to 6.4% in 54 (27.5%) of the participants with IFG and ≥6.5% in 12 (66.6%) of the participants with DM~FPG~. The kappa coefficients for agreement between the FPG and HbA1c results were 0.12 in the youth group and 0.19 in the young adult group, which indicated poor agreement \[[@B28]\].

When an HbA1c cutoff of 5.7% was used to detect IFG, the sensitivity and specificity were 35.0% and 83.9% in the youth group and 33.2% and 90.9% in the young adult group, respectively ([Table 2](#T2){ref-type="table"}). When an HbA1c cutoff of 6.5% was used to detect DM~FPG~, the sensitivity and specificity were 72.2% and 99.9% in the youth group and 66.6% and 99.9% in the young adult group, respectively.

ROC curve analysis of the diagnostic performance of HbA1c
---------------------------------------------------------

In the ROC curve analysis, the AUC (95% CI) for detecting IFG based on HbA1c level was 0.649 (95% CI, 0.648 to 0.650) for the youth group and 0.700 (95% CI, 0.699 to 0.701) for the young adult group (*P*\<0.001) ([Fig. 2A](#F2){ref-type="fig"}). The optimal HbA1c cutoff point for diagnosing IFG was 5.6% (sensitivity 49.9%, specificity 73.3%) in the youth group and 5.5% (sensitivity 54.3%, specificity 72.9%) in the young adult group ([Table 2](#T2){ref-type="table"}).

The AUC (95% CI) for detecting DM~FPG~ based on HbA1c level was 0.996 (95% CI, 0.996 to 0.996) for the youth group and 0.962 (95% CI, 0.962 to 0.963) for the young adult group (*P*\<0.001) ([Fig. 2B](#F2){ref-type="fig"}). The optimal HbA1c cutoff point for diagnosing DM~FPG~ was 5.9% (sensitivity 100%, specificity 95.8%) in the youth group and 5.8% (sensitivity 87.9%, specificity 94.6%) in the young adult group ([Table 2](#T2){ref-type="table"}).

DISCUSSION
==========

By using nationally representative survey data, we assessed the diagnostic performance of HbA1c cutoff values recommended for the diagnosis of IFG and DM~FPG~. Use of an HbA1c cutoff of ≥6.5% for DM~FPG~ resulted in a sensitivity of 72.2% and a specificity of 99.9% in the youth group and a sensitivity of 66.6% and a specificity of 99.9% in the young adult group. However, the HbA1c cutoff of ≥5.7% for IFG had a lower sensitivity and specificity than did the HbA1c cutoff of 6.5% for diabetes in both groups. In the present study, the HbA1c cutoff values that best coincided with the DM~FPG~ were 5.9% in the youth group and 5.8% in the young adult group by using ROC curve analysis. The optimal HbA1c cutoff levels for detecting IFG in the youth and young adult groups were 5.6% and 5.5%, respectively.

Collectively, the data presented above support the use of different HbA1c thresholds for identifying IFG and DM~FPG~ in pediatric and young adult populations. The cutoff values of HbA1c predicting IFG and DM~FPG~ were lower than those recommended by the ADA in the adult population.

In this study population, when HbA1c alone was used as a tool for detecting DM~FPG~, only three youths (0.07%) and five young adults (0.12%) with DM~FPG~ were misdiagnosed with PreDM~A1C~. However, for the diagnosis of IFG using HbA1c, 214 youths (5.3%) and 149 young adults (4.9%) with IFG were misclassified as being normoglycemic ([Table 1](#T1){ref-type="table"}). According to the present study, an HbA1c of 6.5% might play a role in confirming the diagnosis of diabetes in the pediatric population because of high specificity and PPV ([Table 2](#T2){ref-type="table"}). This suggests that HbA1c alone might be insufficient to diagnose IFG in youths and young adults.

When applying the HbA1c cutoff value of 5.6% for IFG in the youth group, the misclassification rate decreased to 4.1% (163 subjects). In the young adult group, applying the HbA1c cutoff of 5.5% to detect IFG decreased misclassification rate to 3.4% (103 subjects). Therefore, in these age groups, lower HbA1c cutoff might be used to detect subjects at risk for development of diabetes.

After adopting HbA1c as a diagnostic test for DM, validation studies were performed in adult and pediatric populations ([Table 3](#T3){ref-type="table"}) \[[@B16][@B17][@B22][@B30][@B31][@B32][@B33]\]. The cutoff values of HbA1c for detecting prediabetes and diabetes were found not to be the same as the values recommended by the ADA.

The HbA1c threshold for prediabetes and diabetes might be associated with the HbA1c levels of a certain population. Populations with higher mean HbA1c levels seemed to show higher HbA1c cutoff values for prediabetes and diabetes. In the present study, young adults aged 20 to 29 years had lower HbA1c cutoff points for IFG and DM~FPG~ than did youths aged 10 to 19 years. Generally, HbA1c levels increase with age \[[@B34]\]. HbA1c thresholds for prediabetes and diabetes also increase with age \[[@B30]\]. However, several studies have revealed that teenagers have higher HbA1c levels than adults in their twenties \[[@B18][@B19]\]. In the general Korean population, mean HbA1c levels were 5.42% for youths aged 10 to 19 years and 5.32% for young adults aged 20 to 29 years \[[@B18]\]. Moreover, Korean youths and young adults showed higher HbA1c levels than did their counterparts in the United States (5.37% from Korea versus 4.99% from the United States) \[[@B18][@B19]\]. HbA1c cutoff points of prediabetes and diabetes in the United States pediatric population was 5.5% and 5.8%, respectively, which was lower than those in Korean youths \[[@B22]\].

In the adult population aged \>30 years, FPG usage, as compared with HbA1c usage, has been found to underestimate diabetes and prediabetes in Korean and Chinese studies \[[@B15][@B35][@B36]\]. However, studies of primarily Caucasians and African Americans in the United States have reported to opposite results \[[@B11][@B21]\]. Ethnic variations in HbA1c levels might be the reason for these results; e.g., Asians have higher HbA1c levels than African Americans and Caucasians \[[@B18][@B19]\]. In the present study, HbA1c alone underestimated IFG and DM~FPG~ in subjects aged \<30 years ([Table 1](#T1){ref-type="table"}). This suggests that additional evaluation by using FPG to detect diabetes and prediabetes might be warranted in those aged \<30 years with lower HbA1c values.

Interestingly, cutoff points for prediabetes and diabetes in the present study corresponded to the 75th and 95th percentiles for both age groups according to recently published Korean reference values for HbA1c (5.6% for the 75th percentile and 5.9% for the 95th percentile in the youth group; 5.5% for the 75th percentile and 5.8% for the 95th percentile in the young adult group) \[[@B18]\]. This implies that an HbA1c value of the 75th percentile among those aged \<30 years might be an appropriate cutoff, rather than the uniform value provided by the ADA. An HbA1c of 6.5%, which was the diagnostic criteria for diabetes, far exceeded over the 99th percentile in the Korean population aged \<30 years.

HbA1c is useful for predicting DM and cardiovascular complications \[[@B11]\]. However, there are discrepancies in the diagnoses of diabetes and prediabetes based on HbA1c versus FPG levels. In the present study, the kappa coefficients indicated poor agreement between HbA1c and FPG results in both groups (0.12 for the youth group and 0.19 for the young adult group). Similar to our findings, others have reported a kappa coefficient of 0.17 for agreement between HbA1c results and 2-hour plasma glucose results of OGTTs for diagnosis of DM in obese children and adolescents \[[@B22]\]. Therefore, HbA1c criteria for the diagnosis of prediabetes and diabetes might be different in children and adults. Glucose- and HbA1c-based test might be complementary in detecting prediabetes and diabetes. Moreover, this approach might help to detect early changes in abnormal glucose metabolism.

In the present study, IFG and DM~FPG~ was defined by FPG levels due to the lack of 2-hour plasma glucose after OGTT. However, FPG elevation within the normal glycemic range in childhood was found to be a reliable marker for future development of diabetes in young adulthood \[[@B5]\]. This result suggests the importance of FPG levels in the pediatric population.

Several factors may influence the variance of HbA1c levels, including the hemoglobin glycosylation rate and the rate of turnover of red blood cells \[[@B37][@B38][@B39]\]. Although we did not evaluate these parameters in this study, we excluded participants with anemia, because iron deficiency has been shown to elevate HbA1c levels.

This study had several limitations. First, only a single fasting sample was examined, which might have caused misclassification bias. Second, OGTT were not performed. Diabetes could be diagnosed based on either FPG or 2-hour plasma glucose. Moreover, variance in HbA1c is affected by both fasting and postprandial glucose. However, in a large-scale survey such as the KNHANES, OGTT could be difficult to apply. Third, because of the cross-sectional study design, whether a current HbA1c value could predict diabetes and its related complications is unclear. In addition, HbA1c could not indicate acute glucose fluctuation or variation. Fourth, the low number of patients with diabetes in the youth group might have affected the statistical significance (DM~FPG~ 0.23%, DM~A1C~ 0.23% in the youth group; DM~FPG~ 0.58%, DM~A1C~ 0.46% in the young adult group). The strength of the present study is the comparison between the diagnostic performance of HbA1c in youth and young adult groups by using nationally representative data.

In summary, although HbA1c has been recommended as a diagnostic marker for diabetes and prediabetes in adults, its usefulness in children and adolescents remains unclear owing to the disparity between the results of glucose- and HbA1c-based tests. Lower optimal HbA1c cutoff values for the diagnosis of IFG and DM~FPG~ were observed in youths and young adults as compared with those recommended for adults. Therefore, a lower HbA1c level for the detection of prediabetes and diabetes, as compared to that recommended by the ADA, might be more appropriately applied to the Korean population aged \<30 years. Prospective studies that include OGTTs are needed to clarify the diagnostic role of HbA1c in both diabetes and prediabetes in pediatric and young adult populations.
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###### Supplementary Table 1

Clinical characteristics of the study participants

![Flow chart for the selection of study participants. KNHANES, Korea National Health and Nutrition Examination Survey; HbA1c, glycosylated hemoglobin.](dmj-43-174-g001){#F1}

![Receiver operator characteristic curves for detection of (A) impaired fasting glucose (fasting plasma glucose ≥100 mg/dL) and (B) diabetes mellitus (fasting plasma glucose ≥126 mg/dL) according to glycosylated hemoglobin levels. (A) The area under the curve (AUC) (95% confidence interval \[CI\]) for impaired fasting glucose was 0.649 (95% CI, 0.648 to 0.650) in the youth group (10 to 19 years of age) and 0.700 (95% CI, 0.699 to 0.701) in the young adult group (20 to 29 years of age) (*P*\<0.001). (B) The AUC (95% CI) for diabetes mellitus was 0.996 (95% CI, 0.996 to 0.996) in the youth group and 0.962 (95% CI, 0.962 to 0.963) in the young adult group (*P*\<0.001).](dmj-43-174-g002){#F2}

###### Fasting plasma glucose level according to HbA1c category and age group

![](dmj-43-174-i001)

  Age group   FPG, mg/dL     HbA1c category   Total                      
  ----------- -------------- ---------------- ------------ ------------- -------------
  10--19 yr   \<100          3,135 (83.9)     658 (16.1)   1 (0.02)      3,794 (100)
  (93.6)      (85.1)         (9.3)            (91.9)                     
  100--125    214 (66.9)     110 (32.5)       3 (0.6)      327 (100)     
  (6.4)       (14.7)         (18.5)           (7.9)                      
  ≥126        0 (0)          3 (27.8)         5 (72.2)     8 (100)       
  \(0\)       (0.4)          (72.2)           (0.2)                      
  Total       3,349 (82.4)   771 (17.4)       9 (0.2)      4,129 (100)   
  \(0100\)    \(0100\)       \(0100\)         \(0100\)                   
  20--29 yr   \<100          2,702 (90.9)     276 (9.1)    0 (0)         2,978 (100)
  (94.5)      (80.8)         \(0\)            (92.6)                     
  100--125    149 (71.5)     54 (27.5)        2 (1.0)      205 (100)     
  (5.5)       (18.0)         (15.1)           (6.8)                      
  ≥126        2 (12.1)       5 (21.3)         12 (66.6)    20 (100)      
  (0.1)       (1.2)          (84.9)           (0.6)                      
  Total       2,853 (89.1)   335 (10.4)       15 (0.5)     3,203 (100)   
  \(100\)     \(100\)        \(100\)          \(100\)                    

Values are presented as number (weighted % of rows) (weighted % of columns). The kappa coefficient was 0.12 for 10 to 19 years and 0.19 for 20 to 29 years.

HbA1c, glycosylated hemoglobin; FPG, fasting plasma glucose.

###### Diagnostic performance of HbA1c according to cutoff values by the present study and ADA/KDA

![](dmj-43-174-i002)

  Criteria         Age group   No. (weighted %)      HbA1c cutoff, %       Sensitivity, %   Specificity, %   PPV, %   NPV, %
  ---------------- ----------- --------------------- --------------------- ---------------- ---------------- -------- --------
  FPG ≥100 mg/dL   10−19 yr    335 (8.1)             5.6 (present study)   49.9             73.3             14.2     94.3
  5.7 (ADA/KDA)    35.0        83.9                  16.1                  93.6                                       
  20−29 yr         225 (7.4)   5.5 (present study)   54.3                  72.9             13.8             95.2     
  5.7 (ADA/KDA)    33.2        90.9                  22.6                  94.5                                       
  FPG ≥126 mg/dL   10−19 yr    8 (0.2)               5.9 (present study)   100              95.8             5.34     100
  6.5 (ADA/KDA)    72.2        99.9                  72.2                  99.9                                       
  20−29 yr         20 (0.6)    5.8 (present study)   87.9                  94.6             8.8              99.9     
  6.5 (ADA/KDA)    66.6        99.9                  85.0                  99.8                                       

HbA1c, glycosylated hemoglobin; ADA, American Diabetes Association; KDA, Korean Diabetes Association; PPV, positive predictive value; NPV, negative predictive value; FPG, fasting plasma glucose.

###### Cutoff values of glycosylated hemoglobin for prediabetes and diabetes

![](dmj-43-174-i003)

  Country         Age, yr     Degree of obesity      Cutoff value, %   Reference
  --------------- ----------- ---------------------- ----------------- ------------
  Korea           50±13       NA                     Prediabetes 5.7   \[[@B30]\]
  Diabetes 6.1                                                         
  China           52.4±13.3   NA                     Prediabetes 5.6   \[[@B31]\]
  Diabetes 6.1                                                         
  Asia & Europe   NA          NA                     Diabetes 6.1      \[[@B32]\]
  USA             13.2±2.8    Obese                  IGT 5.5           \[[@B22]\]
  T2DM 5.8                                                             
  UK              5--15       NA                     IFG 5.4           \[[@B33]\]
  Korea           9.9±3.0     Overweight and obese   IGT 5.8           \[[@B16]\]
  Korea           13.0±2.5    Overweight and obese   Prediabetes 5.8   \[[@B17]\]
  Diabetes 6.2                                                         

Values are presented as mean±standard deviation or range.

NA, not available; IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus; IFG, impaired fasting glucose.
